LeMaitre Vascular Inc (LMAT)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.79B
Last updated: Nov 17, 2026 at 11:06 AM ET
LeMaitre Vascular Inc (LMAT) P/E Ratio & Valuation History
LeMaitre Vascular (LMAT) trades at 28.0x trailing earnings and 6.5x sales. Its P/E of 28.0x is below its 5-year median of 43.0x. Its forward P/E is 24.9x. The median P/E across 9 similar companies is 21.2x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 12.4% higher over the next year. Its free cash flow yield is 3.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 28.0x |
| Forward P/E | 24.9x |
| Price to sales | 6.5x |
| Price to book | 4.1x |
| EV/EBITDA | 22.3x |
| Price to FCF | 26.3x |
| EV/FCF | 28.4x |
| PEG | 2.1 |
| FCF yield | 3.8% |
Historical Medians
Against its 10-year medians, its P/E is 32.0% below 41.2x, its P/S is 3.0% below 6.7x and its P/B is 18.0% below 5.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 28.0x | 43.0x | 41.2x |
| P/S | 6.5x | 7.6x | 6.7x |
| P/B | 4.1x | 4.9x | 5.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 29.6x in 2018 to 47.5x in 2024.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $81.10 | 32.3x | 7.4x | 4.7x |
| 2024 | $92.14 | 47.5x | 9.5x | 6.3x |
| 2023 | $56.76 | 42.0x | 6.5x | 4.3x |
| 2022 | $46.02 | 43.4x | 6.3x | 3.8x |
| 2021 | $50.23 | 39.9x | 6.9x | 4.4x |
| 2020 | $40.50 | 38.2x | 6.4x | 4.8x |
| 2019 | $35.95 | 40.9x | 6.1x | 5.0x |
| 2018 | $23.64 | 29.6x | 4.4x | 3.7x |
| 2017 | $31.84 | 37.5x | 6.1x | 5.9x |
| 2016 | $25.34 | 46.1x | 5.3x | 5.7x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LMAT
What is LMAT's forward P/E ratio?
LeMaitre Vascular has a forward P/E ratio of 24.9x.
Is LMAT stock overvalued?
GNG's valuation label for LMAT is Undervalued. Its P/E of 28.0x compares with a median of 21.2x across 9 similar companies.
What is LMAT's price to sales ratio?
LeMaitre Vascular has a price to sales ratio of 6.5x.
What is LeMaitre Vascular's average P/E ratio over 5 years?
LeMaitre Vascular's median P/E over the last 5 years is 43.0x, from 60 month-end values through Oct 2026.
What is LMAT's PEG ratio?
LeMaitre Vascular has a PEG ratio of 2.1.
LMAT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts